Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin and Ampicillin for Late PPROM
NCT07183462Phase 4Recruiting
- Sponsor
- Sheba Medical Center
- Start
- Sep 2025
- Primary completion
- Jun 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in preterm premature rupture of membranes (pPROM), sponsored by Sheba Medical Center. Started Sep 2025; status: recruiting.
02
Drugs
azithromycin
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT07183462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07183462.